Sophia Randolph
2021
In 2021, Sophia Randolph earned a total compensation of $4.8M as Chief Medical Officer at ALX ONCOLOGY HOLDINGS.
Compensation breakdown
| Non-Equity Incentive Plan | $181,280 |
|---|---|
| Option Awards | $4,116,990 |
| Salary | $453,200 |
| Total | $4,751,470 |
Randolph received $4.1M in option awards, accounting for 87% of the total pay in 2021.
Randolph also received $181.3K in non-equity incentive plan and $453.2K in salary.
Rankings
In 2021, Sophia Randolph's compensation ranked 2,774th out of 12,415 executives tracked by ExecPay. In other words, Randolph earned more than 77.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,774 out of 12,415 | 78th |
Division Manufacturing | 1,096 out of 5,505 | 80th |
Major group Chemicals And Allied Products | 433 out of 2,375 | 82nd |
Industry group Drugs | 378 out of 2,096 | 82nd |
Industry Pharmaceutical Preparations | 254 out of 1,546 | 84th |
Source: SEC filing on April 24, 2023.
Randolph's colleagues
We found two more compensation records of executives who worked with Sophia Randolph at ALX ONCOLOGY HOLDINGS in 2021.